Medicines, 2015
Shortlist up to four to read them side by side.
2,020 medicine recalls FDA’s Enforcement Report published in 2015, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 6, 2026.
2,020of 2,020 medicine recallsshown with your filters
The list
- Medicine recall Amikacin various strength in normal saline bags Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Aztreonam 1 gram in normal saline Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Cefepime various strengths in normal saline Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Cefoxitin various strength in normal saline bags Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Ceftazidime various strength in normal saline bags Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Imipenem/ cilastatin various strength in normal saline bags Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Ertapenem various strength in normal saline bags Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Piperacillin/ tazobactam various strength in normal saline bags Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Vancomycin various strengths in normal saline bags Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Cefuroxime various strengths in normal saline bags Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Meropenem various strengths in normal saline bags Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Nafcillin various strengths in sterile water for injection bags Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Cefazolin various strengths in normal saline bags Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Tobramycin various strengths in normal saline bags Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Gentamicin various strength in normal saline bags Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Daptomycin various strengths in normal saline bags Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Ceftriaxone various strengths in normal saline Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Levofloxacin various strengths in normal saline Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Linezolid various strengths in dextrose Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Tigecycline various strengths in normal saline Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Acyclovir various strengths in normal saline Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Milrinone various strengths in dextrose Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Caspofungin various strengths in normal saline Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Dobutamine various strengths in dextrose Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Dopamine various strengths in dextrose Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Folic acid 1 mg/ 0.2 ml pre-drawn syringes Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Thiamine 100 mg/ ml vials Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Ranitidine various strengths in syringes Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Magnesium sulfate various strengths in sodium chloride Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Deferoxamine various strengths in normal saline Lack of sterility assurance. Class IIIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Dehydrated alcohol vials Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Diphenhydramine 50 mg/ml vials Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Immune globulin g human various strengths Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall L-cysteine various strengths Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall Total parenteral nutrition various strengths Lack of sterility assurance. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement Report6 statesnamed in where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereFlorida, Georgia, Louisiana, Mississippi, Texas and Virginia
- Medicine recall 3M ESPE Clinpro 5000 Labeling: Incorrect or Missing Lot and/or Exp. Class IIIFDA’s classJan 28, 2015in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 28, 2015ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall CIPROFLOXACIN TABLETS, USP, 500 mg, 100 Tablets CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices Class IIFDA’s classJan 28, 2015in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall LAMOTRIGINE TABLETS, 200 mg, 100 Tablets CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices Class IIFDA’s classJan 28, 2015in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol… Non-Sterility: Valeant’s laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull. Class IIFDA’s classJan 28, 2015in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 28, 2015ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Glycopyrrolate injection, 0.2 mg per mL Labeling: Incorrect or missing Lot and/or Exp Date: Printing error caused an overlap in the “y” and “3” making the actual “Use By 3/2015” date appear to read… Class IIFDA’s classJan 21, 2015in FDA’s Enforcement ReportLouisianathe one state its words name PublishedJan 21, 2015ClassClass IIStatusTerminatedWhereLouisiana
- Medicine recall Gabapentin Capsules, USP 300 mg, 100-count bottles Failed Tablet/Capsule Specifications: Complaints of empty capsules received. Class IIFDA’s classJan 14, 2015in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 14, 2015ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall ACETAMINOPHEN and CODEINE PHOSPHATE ORAL SOLUTION USP, 120 mg/12 mg per 5 mL Failed Impurities/Degradation Specifications: High out of specification results for the known impurity p-Aminophenol. Class IIIFDA’s classJan 14, 2015in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 14, 2015ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall HydrALAZINE Hydrochloride Tablets, USP 25 mg, 100 count bottle Presence of Foreign Substance: Par Pharmaceutical, Inc. Class IIFDA’s classJan 14, 2015in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 14, 2015ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Triamcinolone Acetonide Lotion USP, 0.025% is supplied in the following size: 60 mL (NDC 61748-219-60). Failed Impurities/Degradation Specifications: The known impurity went out of specification at 12 months stability point. Class IIIFDA’s classJan 14, 2015in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 14, 2015ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall 0.9% Sodium Chloride Injection, USP, 100mL, VisIV Container Lack of Assurance of Sterility: The product has the potential for solution to leak at the administrative port. Class IIFDA’s classJan 14, 2015in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 14, 2015ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Glutathione 200 mg/mL Injectable Incorrect Product Formulation: An incorrect gas was used to remove the oxygen from the vial. Class IIFDA’s classJan 14, 2015in FDA’s Enforcement Report3 statesnamed in where it went PublishedJan 14, 2015ClassClass IIStatusTerminatedWhereKansas, Missouri and Texas
- Medicine recall Gabapentin Capsules, USP, 400 mg Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle… Class IIFDA’s classJan 14, 2015in FDA’s Enforcement ReportPuerto Ricothe one state its words name PublishedJan 14, 2015ClassClass IIStatusTerminatedWherePuerto Rico
- Medicine recall Gabapentin Capsules, USP, 300 mg Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle… Class IIFDA’s classJan 14, 2015in FDA’s Enforcement ReportPuerto Ricothe one state its words name PublishedJan 14, 2015ClassClass IIStatusTerminatedWherePuerto Rico
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.